Kumar Ravindra 4
4 · ACCELERON PHARMA INC · Filed Jan 29, 2019
Insider Transaction Report
Form 4
Kumar Ravindra
VP & Chief Scientific Officer
Transactions
- Award
Option to Purchase Common Stock
2019-01-25+21,500→ 21,500 totalExercise: $41.64Exp: 2029-01-25→ Common Stock (21,500 underlying) - Award
Common Stock
2019-01-25+3,850→ 93,997 total
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2019.